A Trial of Triamcinolone With a GnRH Analog for Castration Resistant Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 19, 2011

Primary Completion Date

September 24, 2020

Study Completion Date

September 24, 2020

Conditions
Castration Resistant Prostate Cancer
Interventions
DRUG

Triamcinolone acetonide IM injection

"An initial loading dosage will be given and then every 4 weeks the patient will be given triamcinolone. Triamcinolone acetonide IM injection should be administered as per individual sites local procedures.~The number of Triamcinolone injections, the volume and the site of administration will be documented in the CRF. The initial dose can be split according to local administration procedures.~Cycle 1~Day 1 Week 1 (loading dose given once only)~o 360 mg IM injection~Subsequent cycles (given 4 weekly thereafter until progression +/-3 days)~Day 1~o 120 mg IM injection"

Trial Locations (3)

Unknown

Royal Sussex County Hospital, Brighton

Raigmore Hospital, Inverness

St Bartholomew's Hospital, London

All Listed Sponsors
lead

Barts & The London NHS Trust

OTHER

NCT07161778 - A Trial of Triamcinolone With a GnRH Analog for Castration Resistant Prostate Cancer | Biotech Hunter | Biotech Hunter